2-[(2-ethoxyphenoxy)methyl]morpholine structure
|
Common Name | 2-[(2-ethoxyphenoxy)methyl]morpholine | ||
|---|---|---|---|---|
| CAS Number | 46817-91-8 | Molecular Weight | 237.29500 | |
| Density | 1.061 g/cm3 | Boiling Point | 350.5ºC at 760 mmHg | |
| Molecular Formula | C13H19NO3 | Melting Point | 185-186ºC | |
| MSDS | N/A | Flash Point | 144.3ºC | |
Use of 2-[(2-ethoxyphenoxy)methyl]morpholineViloxazine (Viloxazin) is a norepinephrine reuptake inhibitor, also a potent 5-HT2C agonist and 5-HT2B antagonist with an EC50 of 32 μM and an IC50 of 27 μM for 5-HT2C and 5-HT2B, respectively. The mechanism of action of Viloxazine predominantly involves serotonergic and noradrenergic pathways. Viloxazine can be used for researching depression[1][2]. |
| Name | 2-[(2-ethoxyphenoxy)methyl]morpholine |
|---|---|
| Synonym | More Synonyms |
| Description | Viloxazine (Viloxazin) is a norepinephrine reuptake inhibitor, also a potent 5-HT2C agonist and 5-HT2B antagonist with an EC50 of 32 μM and an IC50 of 27 μM for 5-HT2C and 5-HT2B, respectively. The mechanism of action of Viloxazine predominantly involves serotonergic and noradrenergic pathways. Viloxazine can be used for researching depression[1][2]. |
|---|---|
| Related Catalog | |
| Target |
Human 5-HT2C Receptor:32 μM (EC50) human 5-HT2B Receptor:27 μM (IC50) |
| References |
| Density | 1.061 g/cm3 |
|---|---|
| Boiling Point | 350.5ºC at 760 mmHg |
| Melting Point | 185-186ºC |
| Molecular Formula | C13H19NO3 |
| Molecular Weight | 237.29500 |
| Flash Point | 144.3ºC |
| Exact Mass | 237.13600 |
| PSA | 39.72000 |
| LogP | 1.78130 |
| Index of Refraction | 1.499 |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
|
|
~98%
2-[(2-ethoxyphe... CAS#:46817-91-8 |
| Literature: Audouze, Karine; Nielsen, Elsebet stergaard.; Peters, Dan Journal of Medicinal Chemistry, 2004 , vol. 47, # 12 p. 3089 - 3104 |
|
~%
2-[(2-ethoxyphe... CAS#:46817-91-8 |
| Literature: Supernus Pharmaceuticals Inc. Patent: US2011/251198 A1, 2011 ; Location in patent: Page/Page column 15 ; |
|
~%
2-[(2-ethoxyphe... CAS#:46817-91-8 |
| Literature: Audouze, Karine; Nielsen, Elsebet stergaard.; Peters, Dan Journal of Medicinal Chemistry, 2004 , vol. 47, # 12 p. 3089 - 3104 |
|
~%
2-[(2-ethoxyphe... CAS#:46817-91-8 |
| Literature: Audouze, Karine; Nielsen, Elsebet stergaard.; Peters, Dan Journal of Medicinal Chemistry, 2004 , vol. 47, # 12 p. 3089 - 3104 |
|
~39%
2-[(2-ethoxyphe... CAS#:46817-91-8 |
| Literature: Supernus Pharmaceuticals Inc. Patent: US2011/251198 A1, 2011 ; Location in patent: Page/Page column 13-14 ; |
|
~%
2-[(2-ethoxyphe... CAS#:46817-91-8 |
| Literature: Supernus Pharmaceuticals Inc. Patent: US2011/251198 A1, 2011 ; |
|
~%
2-[(2-ethoxyphe... CAS#:46817-91-8 |
| Literature: Supernus Pharmaceuticals Inc. Patent: US2011/251198 A1, 2011 ; |
|
~%
2-[(2-ethoxyphe... CAS#:46817-91-8 |
| Literature: Letavic, Michael A.; Keith, John M.; Ly, Kiev S.; Bonaventure, Pascal; Feinstein, Mark A.; Lord, Brian; Miller, Kirsten L.; Motley, S. Timothy; Nepomuceno, Diane; Sutton, Steven W.; Carruthers, Nicholas I. Bioorganic and Medicinal Chemistry Letters, 2008 , vol. 18, # 21 p. 5796 - 5799 |
| Emovit |
| Morpholine,2-((2-ethoxyphenoxy)methyl) |
| Viloxazinum [INN-Latin] |
| 2-(2-Ethoxy-phenoxymethyl)-morpholine |
| 2-(o-ethoxyphenoxymethyl)morpholine |
| viloxazine |
| Viloxazina [INN-Spanish] |
| Viloxazin |